The text below is an extract of BOMI Announcement.
Bomi Group is pleased to announce the launch of its 2019-2020 Welfare Plan. This comprehensive and innovative document envisages a system that offers goods and services to those that helped to successfully transfer the company to its new headquarters in Spino d’Adda, in the province of Cremona, as well as several initiatives aimed at improving the wellbeing of workers and their families, by introducing innovative measures regarding their work-life balance.
Although only a pilot scheme in Italy at the moment, there is the plan to implement similar actions across the different regions in the future. It confirms the company’s commitment to sustainability issues, not just those related to the environment, but economic and social sustainability too, placing a particular focus on workers’ health and on creating an inclusive, performing, and innovative work environment.
Several drivers led to the creation of the plan:
- Employee centricity (putting people at the centre of how we operate),
- Work-life balance (promoting a better work-life balance),
- Belonging (strengthening people’s sense of belonging),
- Healthcare (helping to look after workers’ health and wellbeing),
- Accountability & Reliance (increasing people’s accountability and a sense of being able to rely on the company),
- Sustainability (helping to reduce CO2 emissions going into the air),
- Happiness (creating happiness).
To read the full text: Bomi Group launches 2019 2020 Welfare Plan
About ArchiMed - www.archimed-group.eu - ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.
ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large size healthcare companies throughout the world, with a combined value above five billion euros.
ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.